Updating
Most Recent Episode
69. Antibodies in immuno-oncology, Alison O'Neill, Chief Medical Officer, Surface Oncology

69. Antibodies in immuno-oncology, Alison O'Neill, Chief Medical Officer, Surface Oncology

Alison serves as the chief medical officer at Sur…
Time: 19:35
Alison serves as the chief medical officer at Surface Oncology. She has over 20 years of experience in clinical research, oncology drug development and clinical neuro-oncology. Prior to joining Surface, Alison held several leadership roles in clinical research and development at Radius Health, Synta Pharmaceuticals and at Sanofi in the global oncology division. Prior to entering the biotech industry, she served on faculty at Massachusetts General Hospital where she focused on early phase clinical studies and treating patients with malignancies of the central nervous system. Alison earned both her bachelor’s degree and her medical degree from the University of Chicago. She completed her residency training at the University of Michigan in neurology and her neuro-oncology fellowship training at Memorial Sloan-Kettering Cancer Center.
Episode ID: 1000532376286
GUID: tag:soundcloud,2010:tracks/1103740792
Release Date: 18/08/2021, 22:00:05

Description

Biotech 2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.

Apple Podcasts: Customer Reviews

Sounds like a sales pitch

 – 
John-Hernry2
 – 
2021-06-16
I was hoping to hear about some interesting technology, but the first 20 minutes sounded like a sales pitch and slagging competitors. I ran out of patience so couldn’t finish it.